Malik To Step Down As Viatris President Amid Continuing Strategic Shift

Former Matrix And Mylan Executive Will Retire From Current Position In April 2024

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.